Victory Capital Management Inc. grew its position in MAXIMUS, Inc. (NYSE:MMS) by 1.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,011,882 shares of the health services provider’s stock after purchasing an additional 51,283 shares during the quarter. MAXIMUS makes up 0.7% of Victory Capital Management Inc.’s investment portfolio, making the stock its 8th largest position. Victory Capital Management Inc. owned approximately 6.29% of MAXIMUS worth $261,133,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Keybank National Association OH grew its position in shares of MAXIMUS by 13.5% in the 3rd quarter. Keybank National Association OH now owns 24,425 shares of the health services provider’s stock valued at $1,589,000 after buying an additional 2,900 shares during the last quarter. Nordea Investment Management AB grew its position in MAXIMUS by 41.9% during the 3rd quarter. Nordea Investment Management AB now owns 71,423 shares of the health services provider’s stock worth $4,647,000 after purchasing an additional 21,092 shares during the last quarter. AQR Capital Management LLC grew its position in MAXIMUS by 29.6% during the 3rd quarter. AQR Capital Management LLC now owns 906,088 shares of the health services provider’s stock worth $58,950,000 after purchasing an additional 206,896 shares during the last quarter. Cambiar Investors LLC lifted its stake in shares of MAXIMUS by 1.7% in the 4th quarter. Cambiar Investors LLC now owns 70,594 shares of the health services provider’s stock worth $4,595,000 after acquiring an additional 1,163 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in shares of MAXIMUS by 75.5% in the third quarter. Tower Research Capital LLC TRC now owns 7,127 shares of the health services provider’s stock valued at $464,000 after purchasing an additional 3,066 shares during the period. 95.26% of the stock is currently owned by hedge funds and other institutional investors.
MAXIMUS stock traded up $0.55 during trading on Tuesday, reaching $70.23. The company had a trading volume of 2,774 shares, compared to its average volume of 358,175. MAXIMUS, Inc. has a 12-month low of $60.00 and a 12-month high of $72.45. The company has a market cap of $4.46 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 1.91 and a beta of 1.02. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.32 and a current ratio of 2.32.
MAXIMUS (NYSE:MMS) last released its earnings results on Thursday, February 7th. The health services provider reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.06. MAXIMUS had a net margin of 8.94% and a return on equity of 20.09%. The firm had revenue of $664.60 million during the quarter, compared to the consensus estimate of $672.08 million. During the same period in the previous year, the firm earned $0.89 earnings per share. MAXIMUS’s revenue was up 6.7% compared to the same quarter last year. Sell-side analysts predict that MAXIMUS, Inc. will post 3.66 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, February 28th. Investors of record on Friday, February 15th will be issued a $0.25 dividend. The ex-dividend date is Thursday, February 14th. This represents a $1.00 dividend on an annualized basis and a yield of 1.42%. MAXIMUS’s payout ratio is 29.41%.
In related news, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 2nd. The shares were sold at an average price of $64.14, for a total value of $64,140.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Vice Chairman Richard A. Montoni sold 30,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $72.03, for a total transaction of $2,160,900.00. Following the completion of the sale, the insider now owns 429,874 shares of the company’s stock, valued at $30,963,824.22. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 67,902 shares of company stock valued at $4,761,681. 2.20% of the stock is owned by insiders.
A number of brokerages have issued reports on MMS. ValuEngine upgraded shares of MAXIMUS from a “hold” rating to a “buy” rating in a research report on Friday, November 30th. Zacks Investment Research upgraded shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 price target for the company in a report on Friday, November 23rd.
TRADEMARK VIOLATION NOTICE: This article was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2019/02/12/maximus-inc-mms-shares-bought-by-victory-capital-management-inc.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Read More: Cost of equity and a company’s balance sheet
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.